Publications by authors named "Vishnu Modur"

Claim this Profile
L
Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.
Pooja Joshi, Vijayalakshmi Ayyagari, Samikshya Kandel, Vishnu Modur, Muhammad F Iqbal

Biomed Res Int· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects.
Vishnu Modur, Belal Muhammad, Jun-Qi Yang, Yi Zheng, Kakajan Komurov

Cell Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
Khalid W Kalim, Jun-Qi Yang, Mark Wunderlich, Vishnu Modur, Phuong Nguyen

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From Autoimmunity.
Khalid W Kalim, Jun-Qi Yang, Vishnu Modur, Phuong Nguyen, Yuan Li

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers.
Vishnu Modur, Navneet Singh, Belal Muhammad

J Vis Exp· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion.
Reshmi Tripathi, Vishnu Modur, Laura Senovilla, Guido Kroemer, Kakajan Komurov

Oncoimmunology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective transcription elongation in a subset of cancers confers immunotherapy resistance.
Vishnu Modur, Navneet Singh, Vakul Mohanty, Eunah Chung, Belal Muhammad

Nat Commun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of immortalized human mammary epithelial cell line HMEC 2.6.
Pooja S Joshi, Vishnu Modur, JiMing Cheng, Kathy Robinson, Krishna Rao

Tumour Biol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma.
Vishnu Modur, Pooja Joshi, Daotai Nie, K Thomas Robbins, Aziz U Khan

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV and CSC in HNSCC cisplatin resistance.
Vishnu Modur, K Thomas-Robbins, Krishna Rao

Front Biosci (Elite Ed)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.
Hiroshi Okuda, Aya Kobayashi, Bo Xia, Misako Watabe, Sudha K Pai, Vishnu Modur

Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
Wen Liu, Megumi Iiizumi-Gairani, Hiroshi Okuda, Aya Kobayashi, Misako Watabe, Vishnu Modur

J Biol Chem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis